Roche

Roche cracks China's ADC market open as Kadcyla scores its first breast cancer OK in the country
Endpoints
Thu, 01/23/20 - 12:11 pm
Roche
Kadcyla
China
breast cancer
antibody-drug conjugate
Fresh trial data fortify position of Roche's oral therapy in spinal muscular atrophy battleground
Endpoints
Thu, 01/23/20 - 11:57 am
Roche
SMA
FDA
risdiplam
Roche's digital partnerships flourish under live-and-let-live approach
Fierce Pharma
Wed, 01/22/20 - 11:11 am
Roche
digital pharma
Spark Therapeutics
With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans
BioSpace
Wed, 01/15/20 - 10:59 am
drug pricing
Roche
Eli Lilly
Amgen
Alnylam
Sanofi
Roche aims to 'underwhelm' with risdiplam price as it enters SMA rivalry with Biogen, Novartis — report
Endpoints
Tue, 01/14/20 - 10:20 am
SMA
Roche
risdiplam
Biogen
Novartis
drug pricing
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
Mon, 01/13/20 - 11:35 pm
stem cells
MS
multiple sclerosis
NIH
AHSCT
Biogen
Tysabri
Sanofi
Lemtrada
Roche
Ocrevus
Rituxan
Roche Pays $40M to Use Amunix Pharma’s Half-Life Extension Tech
Xconomy
Mon, 01/13/20 - 10:49 am
Roche
Amunix
R&D
half-life extension
XTEN
Merck-partnered biotech hands Roche its half-life extension tech as it pivots to immuno-oncology
Endpoints
Fri, 01/10/20 - 10:21 am
Roche
immuno-oncology
Amunix
Merck
CAR-T
Despite secret discount, Roche's Tecentriq hits NICE roadblock in small-cell lung cancer
Fierce Pharma
Sat, 01/4/20 - 07:31 pm
Roche
Tecentriq
NICE
UK
Small-Cell Lung Cancer
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
M&A
Bristol-Myers Squibb
Celgene
AbbVie
Allergan
Roche
Spark Therapeutics
Novartis
The Medicines Company
Alkermes
Rodin Therapeutics
Sumitomo Dainippon
Roivant
An immuno-oncology triplet from Roche shows promise in mouse models of several tumors
Fierce Biotech
Fri, 01/3/20 - 09:44 am
Roche
targeted antibodies
breast cancer
colon cancer
skin cancer
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
Xconomy
Tue, 12/24/19 - 12:00 am
Roche
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
SRP-9001
Amgen, Allergan join Rituxan biosimilar challenge with FDA filing
Pharmaforum
Fri, 12/20/19 - 12:15 pm
Amgen
Allergan
biosimilar
Roche
Rituxan
Roche's Ocrevus, GSK's Dovato ads top November TV spending charts—behind Humira, of course
Fierce Pharma
Thu, 12/19/19 - 11:06 pm
drug ads
television ads
Roche
Ocrevus
GSK
Dovato
AbbVie
Humira
WHO Prequalifies its First Biosimilar
RAPS.org
Thu, 12/19/19 - 06:01 pm
WHO
biosimilars
Samsung Bioepis
Ontruzant
Roche
Herceptin
breast cancer
Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials
BioSpace
Thu, 12/19/19 - 12:45 pm
Roche
Genentech
Arcus Biosciences
clinical trials
colorectal cancer
pancreatic cancer
AB928
ESMO I-O: Roche silences Tecentriq doubters with latest lung cancer analysis
Fierce Pharma
Tue, 12/17/19 - 09:29 pm
ESMO
Roche
Tecentriq
non-small cell lung cancer
Novartis top of pile in European pharma in 2020, say Jefferies analysts
Pharmaforum
Tue, 12/17/19 - 10:34 am
Novartis
Europe
GSK
Sanofi
AstraZeneca
Roche
Roche's $4.8B deal for Spark cleared by FTC after long delay
Biopharma Dive
Mon, 12/16/19 - 10:46 pm
Roche
Spark Therapeutics
M&A
FTC
Could Spark Therapeutics’ merger with Roche finally get the go-ahead?
Pharmaforum
Mon, 12/16/19 - 10:46 am
Spark Therapeutics
Roche
UK
M&A
CMA

Pages